World's Best Scientists 2026 revealed!
Yutaka Nishiwaki

Yutaka Nishiwaki

D-Index & Metrics

Medicine

D-Index
84
Citations
36784
World Ranking
14868
National Ranking
454

Overview

Yutaka Nishiwaki is affiliated with Tokyo Medical University in Japan. Their research primarily spans the field of Medicine, with a focus across several subfields including Pulmonary and Respiratory Medicine, Epidemiology, Oncology, Cardiology and Cardiovascular Medicine, and Surgery.

The scientist's main research topics encompass diverse areas related to heart and lung diseases, including:

  • Congenital Heart Disease Studies
  • Aortic Disease and Treatment Approaches
  • Lung Cancer Treatments and Mutations
  • Colorectal Cancer Treatments and Studies
  • Gastric Cancer Management and Outcomes
  • Cardiac Valve Diseases and Treatments
  • Cardiac Structural Anomalies and Repair

Yutaka Nishiwaki has contributed to multiple recent scientific papers, covering clinical trials, retrospective cohort studies, and methodological research. These publications include:

  • "Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer," 2023, Journal of Clinical Oncology
  • "Reinterventions and medical costs after tetralogy of Fallot repair: a retrospective cohort study using health insurance claims in Japan," 2025, General Thoracic and Cardiovascular Surgery
  • "Novel transparent patch as an adjunct to adult pulmonary valve replacement," 2025, General Thoracic and Cardiovascular Surgery
  • "Maximum likelihood estimation of mean functions for Gaussian processes under small noise asymptotics," 2025, arXiv (Cornell University)

The scientist frequently publishes in the following venues:

  • General Thoracic and Cardiovascular Surgery
  • Journal of Clinical Oncology
  • arXiv (Cornell University)

Yutaka Nishiwaki has collaborated with several coauthors including:

  • Masahiro Fukuoka
  • Seiji Yano
  • Giuseppe Giaccone
  • Tomohide Tamura
  • Kazuhiko Nakagawa

Best Publications

  • Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma

    Tony S. Mok;Yi Long Wu;Sumitra Thongprasert;Chih Hsin Yang

  • Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer

    Masahiro Fukuoka;Seiji Yano;Giuseppe Giaccone;Tomohide Tamura

  • Irinotecan plus Cisplatin Compared with Etoposide plus Cisplatin for Extensive Small-Cell Lung Cancer

    Kazumasa Noda;Yutaka Nishiwaki;Masaaki Kawahara;Shunichi Negoro

  • Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan

    Y Ohe;Y Ohashi;K Kubota;T Tamura

  • Phase III Study of Concurrent Versus Sequential Thoracic Radiotherapy in Combination With Cisplatin and Etoposide for Limited-Stage Small-Cell Lung Cancer: Results of the Japan Clinical Oncology Group Study 9104

    Minoru Takada;Masahiro Fukuoka;Masaaki Kawahara;Takahiko Sugiura

  • A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer.

    M Fukuoka;H Niitani;A Suzuki;M Motomiya

  • Randomized Trial of Cyclophosphamide, Doxorubicin, and Vincristine Versus Cisplatin and Etoposide Versus Alternation of These Regimens in Small-Cell Lung Cancer

    Masahiro Fukuoka;Kiyoyuki Furuse;Nagahiro Saijo;Yutaka Nishiwaki

  • Video-assisted thoracoscopic surgery for small indeterminate pulmonary nodules: indications for preoperative marking.

    Kenji Suzuki;Kanji Nagai;Junji Yoshida;Hironobu Ohmatsu

  • Phase III Study, V-15-32, of Gefitinib Versus Docetaxel in Previously Treated Japanese Patients With Non–Small-Cell Lung Cancer

    Riichiroh Maruyama;Yutaka Nishiwaki;Tomohide Tamura;Nobuyuki Yamamoto

  • Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer.

    Osamu Kawai;Genichiro Ishii;Kaoru Kubota;Yukinori Murata

  • Interstitial lung disease in Japanese patients with lung cancer: a cohort and nested case-control study.

    Shoji Kudoh;Harubumi Kato;Yutaka Nishiwaki;Masahiro Fukuoka

  • Prognostic implications of fibrotic focus (scar) in small peripheral lung cancers.

    Y Shimosato;A Suzuki;T Hashimoto;Y Nishiwaki

  • Prognostic significance of the size of central fibrosis in peripheral adenocarcinoma of the lung.

    Kenji Suzuki;Tomoyuki Yokose;Junji Yoshida;Mitsuyo Nishimura

  • Breast cancer resistance protein impacts clinical outcome in platinum-based chemotherapy for advanced non-small cell lung cancer.

    Kiyotaka Yoh;Genichiro Ishii;Tomoyuki Yokose;Yuji Minegishi

  • Phase III Randomized Trial of Docetaxel Plus Cisplatin Versus Vindesine Plus Cisplatin in Patients With Stage IV Non-Small-Cell Lung Cancer: The Japanese Taxotere Lung Cancer Study Group

    Kaoru Kubota;Koshiro Watanabe;Hideo Kunitoh;Kazumasa Noda

  • Increased cyclooxygenase 2 (COX-2) expression occurs frequently in precursor lesions of human adenocarcinoma of the lung.

    Yukio Hosomi;Tomoyuki Yokose;Yuko Hirose;Ryu Nakajima

  • Limited resection trial for pulmonary ground-glass opacity nodules: fifty-case experience.

    Junji Yoshida;Kanji Nagai;Tomoyuki Yokose;Mitsuyo Nishimura

  • Visceral pleural invasion is an invasive and aggressive indicator of non-small cell lung cancer.

    Kimihiro Shimizu;Junji Yoshida;Kanji Nagai;Mitsuyo Nishimura

  • Progression of focal pure ground-glass opacity detected by low-dose helical computed tomography screening for lung cancer.

    Ryutaro Kakinuma;Hironobu Ohmatsu;Masahiro Kaneko;Masahiko Kusumoto

  • First-Line Single Agent Treatment With Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer: A Phase II Study

    Seiji Niho;Kaoru Kubota;Koichi Goto;Kiyotaka Yoh

Frequent Co-Authors

Kanji Nagai
Kanji Nagai Kitasato University
Nagahiro Saijo
Nagahiro Saijo AstraZeneca (United Kingdom)
Yuichiro Ohe
Yuichiro Ohe National Cancer Centre
Tomohide Tamura
Tomohide Tamura St. Luke's International Hospital
Masahiro Fukuoka
Masahiro Fukuoka Kindai University
Atsushi Ochiai
Atsushi Ochiai University of Tokyo
Kenji Suzuki
Kenji Suzuki Juntendo University
Kazuhiko Nakagawa
Kazuhiko Nakagawa Kindai University
Yosuke Uchitomi
Yosuke Uchitomi National Cancer Research Institute, UK
Tatsuo Akechi
Tatsuo Akechi Nagoya City University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in studying Medicine in the USA, there are several alternative online degrees and career pathways in the healthcare sector worth exploring. For those drawn to the management side of healthcare, earning a healthcare administration online degree can prepare you for leadership roles in hospitals, clinics, and healthcare organizations. This path offers flexibility and strong job prospects without the need for a medical license.

Aspiring nurses may consider various bridge programs to advance their roles. Options like rn to np programs help registered nurses move efficiently towards becoming nurse practitioners—unlocking higher earning potential and professional autonomy.

For those with an interest in nutrition and wellness, an online nutritionist degree can pave the way for careers in clinical settings, wellness centers, or private practice.

If your goal is executive management in healthcare, the best online mha programs provide robust training for top leadership roles and policy positions.

Best Scientists Citing Yutaka Nishiwaki

Trending Scientists

Recently Published Articles